Fermenta Biotech Ltd.
FERMENTA
Rank in Stocks
#18241
Fermenta Biotech Ltd. primarily focuses on the creation and provision of... Fermenta Biotech Ltd. primarily focuses on the creation and provision of Vitamin D3. Their extensive range of offerings includes various forms like crystalline, oil, resin in oil, cold water dispersible (CWD) preparations, and feed-grade powder. These adaptable products are utilized across multiple sectors, such as in pharmaceutical injectables, soft gel capsules, premixes, and for enhancing the nutritional value of food and beverages. The company's business activities are structured into two main divisions: the Chemicals/Bulk Drug segment, which involves the production and sale of chemicals, pharmaceutical ingredients, and enzymes; and the Property segment, dedicated to leasing out real estate. Established on May 1, 1951, by Vijay Kumar Raju Datla, the firm maintains its headquarters in Mumbai, India.
Share Price
$4.87
Last synced: 2026-11-18
Market Cap
$136.31M
Change (1 day)
-1.52%
Change (1 year)
54.90%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Fermenta Biotech Ltd. (FERMENTA)
Category
Healthcare
Operating Margin for Fermenta Biotech Ltd. (FERMENTA)
Operating Margin as of November 2026 TTM: 11.84%
According to Fermenta Biotech Ltd.'s latest financial reports, its current operating margin (TTM) is 11.84%. At the end of 2025 the company had an operating margin of 18.23%.
Operating Margin history for Fermenta Biotech Ltd. from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 11.84% | -35.05% |
| 2025 | 18.23% | 1,513.27% |
| 2024 | 1.13% | -155.67% |
| 2023 | -2.03% | -121.92% |
| 2022 | 9.26% | -79.41% |
| 2021 | 44.97% | 189.20% |
| 2020 | 15.55% | -51.50% |
| 2019 | 32.06% | 23.50% |
| 2018 | 25.96% | -3,154.12% |
| 2017 | -0.85% | -110.63% |
| 2016 | 8.00% | 36.05% |
| 2015 | 5.88% | -51.28% |
| 2014 | 12.07% | -6.51% |
| 2013 | 12.91% | 132.19% |
| 2012 | 5.56% | -10.75% |
| 2011 | 6.23% | 309.87% |
| 2010 | 1.52% | -121.35% |
| 2009 | -7.12% | 286.96% |
| 2008 | -1.84% | -83.35% |
| 2007 | -11.05% | -384.06% |
| 2006 | 3.89% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -195.39% | -116.50% |
US
|
|
| 33.87% | -97.14% |
US
|
|
| -116.04% | -109.80% |
US
|
|
| 25.57% | -97.84% |
AU
|
|
| 31.23% | -97.36% |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Fermenta Biotech Ltd.'s operating margin
What is Fermenta Biotech Ltd.'s operating margin?
Fermenta Biotech Ltd.'s operating margin is 11.84%, as of Nov 2026.
What was Fermenta Biotech Ltd.'s operating margin in 2025?
In 2025, Fermenta Biotech Ltd.'s operating margin was 18.23%, compared with 1.13% in 2024.
How has Fermenta Biotech Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Fermenta Biotech Ltd.'s operating margin was highest in 2021 (44.97%) and lowest in 2023 (-2.03%).
How does Fermenta Biotech Ltd.'s operating margin compare with similar companies?
Fermenta Biotech Ltd.'s operating margin (11.84%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.